We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Fed. Circ. OKs PTAB Save Of Patent Covering Pfizer’s Toviaz

Law360 (January 11, 2019, 6:15 PM EST) -- The Federal Circuit ruled Friday that a patent on Pfizer Inc.’s incontinence drug Toviaz was correctly upheld in an inter partes review challenge from generics maker Amerigen Pharmaceuticals Ltd., while rejecting...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.